GlaxoSmithKline Pharmaceuticals informs about certificate

07 Oct 2021 Evaluate

In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, GlaxoSmithKline Pharmaceuticals has informed that it enclosed a copy of the Certificate received from Kfintech Technologies, the Registrar and share Transfer Agent of the Company, for the quarter ended 30th September 2021.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2405.45 16.10 (0.67%)
31-Dec-2025 10:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1716.00
Dr. Reddys Lab 1262.50
Cipla 1493.45
Zydus Lifesciences 910.15
Lupin 2086.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×